Compass Therapeutics, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report0 of 7 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Fund move
Fund move
No thesis.
Compass Therapeutics, Inc.
0.79
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Tang Capital ManagementTang | $39.4M | 10.83% | +7.15% | |
| 2 | Orbimed AdvisorsOrbimed | $33.3M | 9.16% | 0.00% | |
| 3 | Suvretta Capital ManagementSuvretta | $30.9M | 8.49% | −1.44% | |
| 4 | BlackRockBlackRockindex-like | $24.7M | 6.79% | +18.68% | |
| 5 | State StreetState Streetindex-like | $21.8M | 5.99% | +48.67% | |
| 6 | Enavate Sciences GPEnavate Sciences GP | $17.1M | 4.69% | 0.00% | |
| 7 | Vivo CapitalVivo Capital | $17.0M | 4.67% | −18.74% | |
| 8 | Vanguard Capital ManagementVanguardindex-like | $13.4M | 3.68% | +1.35% | |
| 9 | Palo Alto InvestorsPalo Alto Investors | $12.8M | 3.51% | +285.06% | |
| 10 | Millennium ManagementMillennium | $10.3M | 2.84% | +456.98% | |
| 11 | Geode Capital ManagementGeodeindex-like | $8.4M | 2.30% | +6.99% | |
| 12 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $8.3M | 2.27% | +248.31% | |
| 13 | Citadel AdvisorsCitadel | $8.1M | 2.23% | +316.33% | |
| 14 | Qube Research & TechnologiesQube Research & Technologies | $8.1M | 2.22% | +44.59% | |
| 15 | Blue Owl Capital HoldingsBlue Owl Capital | $7.9M | 2.18% | +23.20% | |
| 16 | Goldman Sachs GroupGoldman Sachs | $7.7M | 2.13% | +76.96% | |
| 17 | Rock Springs Capital ManagementRock Springs | $7.7M | 2.12% | +6.64% | |
| 18 | AQR Capital ManagementAQR | $7.7M | 2.11% | +1650.82% | |
| 19 | Birchview CapitalBirchview Capital | $3.7M | 1.01% | +14.27% | |
| 20 | Kingdon Capital ManagementKingdon | $3.1M | 0.84% | new | |
| 21 | Fisher Asset ManagementFisher | $3.0M | 0.84% | +3.24% | |
| 22 | Royce & AssociatesRoyce & | $2.9M | 0.80% | −17.47% | |
| 23 | FMRFMR | $2.7M | 0.73% | −32.72% | |
| 24 | Adage Capital Partners GPAdage Capital Partners GP | $2.6M | 0.71% | −86.02% | |
| 25 | Acadian Asset ManagementAcadian | $2.5M | 0.70% | new |
215 managers report $363.7M of Compass Therapeutics on form 13F for the quarter ended Jun 30 '26. 20 of them hold 80% of it; Tang is largest at 10.83%.
Expected move
Inputsspot 0.79exp Nov 20ATM strike 1ATM straddle 0.30IV 148%